Molecular determinants of dysplasia in colorectal lesions

J Jen, SM Powell, N Papadopoulos, KJ Smith… - Cancer research, 1994 - AACR
J Jen, SM Powell, N Papadopoulos, KJ Smith, SR Hamilton, B Vogelstein, KW Kinzler
Cancer research, 1994AACR
One hallmark of malignant potential is dysplasia, the disruption of normal morphology. While
it is generally recognized that cancer is the result of a series of genetic changes, the
relationship of these alterations and their timing to the advent of dysplasia remains obscure.
To address this issue, 54 small benign colorectal lesions of various malignant potential were
analyzed for APC and K-RAS mutations, two alterations which have been implicated in the
early stages of colorectal tumorigenesis. APC mutations were closely associated with …
Abstract
One hallmark of malignant potential is dysplasia, the disruption of normal morphology. While it is generally recognized that cancer is the result of a series of genetic changes, the relationship of these alterations and their timing to the advent of dysplasia remains obscure. To address this issue, 54 small benign colorectal lesions of various malignant potential were analyzed for APC and K-RAS mutations, two alterations which have been implicated in the early stages of colorectal tumorigenesis. APC mutations were closely associated with dysplasia. In contrast, K-RAS mutations were found to be remarkably common in small nondysplastic lesions which apparently have a limited potential to progress to larger tumors. These results provide evidence that the nature and order of genetic changes can have a specific impact on both tumor morphology (e.g., dysplasia) and the likelihood of tumor progression.
AACR